B-cell depletion

NEW YORK, July 6, 2026 TG Therapeutics, Inc. announced the initiation of a Phase 2 clinical trial evaluating BRIUMVI®...

SAN DIEGO, California, May 19, 2026 Artiva Biotherapeutics announced multiple data presentations at the upcoming EULAR 2026 Congress highlighting...

Emeryville, California, October 29, 2025 — Kyverna Therapeutics Inc. (Nasdaq: KYTX) announced positive interim Phase 2 data from the...